Interpretation and validation of interim positron emission tomography in Hodgkin lymphoma

Leuk Lymphoma. 2010 Mar;51(3):552-3. doi: 10.3109/10428190903585468.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic
  • Fluorodeoxyglucose F18 / pharmacology
  • Hodgkin Disease / diagnosis*
  • Hodgkin Disease / diagnostic imaging*
  • Hodgkin Disease / drug therapy
  • Humans
  • Multicenter Studies as Topic
  • Neoplasm Staging
  • Positron-Emission Tomography / methods*
  • Prognosis
  • Radiopharmaceuticals / pharmacology
  • Reference Standards
  • Reproducibility of Results

Substances

  • Antineoplastic Agents
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18